Unveiling the clinicopathological enigma of crawling-type gastric adenocarcinoma

doi:10.4251/wjgo.v16.i11.4321

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (400)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

315

Sum=334

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=51

Nov 15, 2024 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Nov 15, 2024; 16(11): 4321-4325
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4321

Unveiling the clinicopathological enigma of crawling-type gastric adenocarcinoma

Grigorios Christodoulidis, Sara E Agko, Marina N Kouliou, Konstantinos E Koumarelas

Grigorios Christodoulidis, Marina N Kouliou, Konstantinos E Koumarelas, Department of General Surgery, University Hospital of Larissa, University of Thessaly, Biopolis Campus, Larissa 41110, Greece

Sara E Agko, Department of Orthopedic, University Hospital of Larissa, Larissa 41110, Greece

Author contributions: Christodoulidis G, Agko SE, Koumarelas KE and Kouliou MN contributed to this paper; Christodoulidis G designed the overall concept and outline of the manuscript; Christodoulidis G, Agko SE, Koumarelas KE and Kouliou MN contributed to the discussion and design of the manuscript; Christodoulidis G, Agko SE, Koumarelas KE and Kouliou MN contributed to the writing, editing the manuscript, and review of the literature.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Grigorios Christodoulidis, MD, PhD, Academic Editor, Department of General Surgery, University Hospital of Larissa, University of Thessaly, Biopolis Campus, Mezourlo, Larissa 41110, Greece. gregsurg@yahoo.gr

Received: March 23, 2024
Revised: May 14, 2024
Accepted: June 11, 2024
Published online: November 15, 2024
Processing time: 215 Days and 15.2 Hours

Core Tip

Core Tip: Crawling-type adenocarcinoma has specific features, such as irregularly fused glands and low-grade cellular atypia, resembling intestinal metaplasia. Given this, precise attention to its histological characteristics is crucial when diagnosing “crawling-type” adenocarcinoma (CRA). Early detection of CRA is challenging which leads to the importance of the detection of molecular markers and thorough biopsy analysis for accurate classification and clinical management strategies.